Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer Ingelheim

Showing 15 posts of 116 posts found.

Petition launched to raise AF and stroke awareness

April 20, 2012
Business Services, Medical Communications, Sales and Marketing AF, Boehringer Ingelheim, Pradaxa, Xarelto, stroke

Various health organisations have called on more people involved in the management of atrial fibrillation (AF) to help raise awareness …

News
Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012
Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

News
Pradaxa image

Boehringer censured over Pradaxa website

March 8, 2012
Medical Communications ABPI, Boehringer Ingelheim, PMCPA, Pradaxa

Boehringer Ingelheim has breached the ABPI’s Code of Conduct over the use of its Pradaxa website.    Pradaxa is a …

News
Boehringer picture

Boehringer to invest €17m in Biberach, Vienna facilities

March 6, 2012
Manufacturing and Production Austria, BI-HEX, Boehringer Ingelheim, Vienna, manufacturing

Boehringer Ingelheim has said it plans to invest around €17 million in its biopharmaceutical development and manufacturing capabilities at Biberach, …

News
Boehringer picture

Boehringer broadens afatinib studies

January 27, 2012
Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, afatinib

Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …

News
Boehringer pic

Boehringer invests $65 million in early R&D centre

November 16, 2011
Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim is investing $65 million for an early-stage research and development centre in the US. The new 72,000 sq.ft. …

News
Boehringer Facebook image

Boehringer developing Facebook game

November 15, 2011
Medical Communications Boehringer Ingelheim, Facebook

Boehringer Ingelheim is developing a new Facebook civilisation game in the hopes of helping the public understand the difficulty involved …

News

Boehringer hails hepatitis C candidate

November 9, 2011
Sales and Marketing BI201335, Boehringer Ingelheim, HCV, Incivo, Victrelis, hepatitis C

Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …

News

Once daily Viramune set for approval in Europe

August 1, 2011
Sales and Marketing Boehringer Ingelheim, HIV

European regulators have recommended the approval of a new, once-daily form of Boehringer Ingelheim’s HIV treatment Viramune. Viramune (nevirapine) has …

News

Spiriva mist inhaler safety concerns raised

June 16, 2011
Sales and Marketing Boehringer Ingelheim, Spiriva, drug safety

A mist inhaler used to deliver Spiriva to patients with chronic obstructive pulmonary disease (COPD) may be linked to an …

News
Boehringer Ingelheim and Lilly's diabetes drug Tradjenta

Boehringer-Lilly launch diabetes drug Tradjenta in US

June 16, 2011
Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Boehringer Ingelheim and Eli Lilly’s new type II diabetes treatment Tradjenta has been launched in the US. Tradjenta (linagliptin) is …

News

US approval for Boehringer’s diabetes drug Tradjenta

May 3, 2011
Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Tradjenta, the once-daily oral type II diabetes treatment developed by Boehringer Ingelheim, has been approved by US regulators. The FDA …

News
Boehringer Ingelheim

Boehringer begins late-stage hep C trial

April 27, 2011
Research and Development BI 201335, Boehringer Ingelheim, hepatitis C

Boehringer Ingelheim has begun enrolling patients in North America for a phase III trial of its chronic hepatitis C virus …

News

Digital Pharma: Boehringer UK tweets politicians with afib message

April 21, 2011
Medical Communications Boehringer Ingelheim, Digital Pharma blog, Twitter, medical communications

Boehringer Ingelheim UK is using Twitter to reach politicians with local disease awareness messages. About a third of MPs have …

News
Boehringer Ingelheim

Boehringer’s Pradaxa recommended for expanded European licence

April 18, 2011
Sales and Marketing Boehringer Ingelheim, CHMP, Pradaxa

Pradaxa is on course to expand its European licence with a recommendation from the CHMP for a new indication in …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026